openPR Logo
Press release

Closed Transfer Systems for Hazardous Drugs Preparing for Change as New Standards Approach

06-08-2017 07:25 PM CET | Health & Medicine

Press release from: Greystone Research Associates

(Amherst, NH) – In the specialized area of oncology, the use of substances that can harm as well as benefit is common. The danger extends to hospital pharmacy compounders and caregivers, as well as the patient. A specialized area of drug handling systems known as closed system transfer is comprised of a small number of devices that are designed to protect workers and patients by limiting exposure to harmful substances during the creation and administration of these drugs. New standards and guidelines will increase the adoption rate of this class of devices, which will grow at CAGR of 11 percent over the next eight years.

Closed system transfer device (CSTD) technology is founded in the need to protect patients and caregivers from exposure to hazardous drugs. The risks of occupational exposure to hazardous drugs have been known since the 1970s. Since 1980, guidance documents from the American Society of Health-System Pharmacists (ASHP) and the National Institute for Occupational Safety and Health (NIOSH) have provided advice to healthcare providers who manage these agents, but adoption has not always been consistent or comprehensive. On February 1, 2016, United States Pharmacopeia (USP) General Chapter 800: “Hazardous Drugs: Handling in Healthcare Settings” was published, and will provide the first enforceable standards concerning hazardous drugs beginning on July 1, 2018.

The primary application for CSTDs is oncology therapeutics, a disease sector that still relies heavily on hazardous substances, in spite of the increasing promise of targeted antibody treatments based on tumor-specific biomarkers. Hazardous drugs include neoplastic drugs, cytotoxic drugs such as alkylating agents and antimetabolites, and drugs that represent reproductive risk. These drugs are believed to represent a significant occupational exposure risk for hospital pharmacy and infusion center personnel.

Although CSTDs do not guarantee 100% protection, they provide significantly more of it than without them. Many studies have been done to evaluate the use of a CSTD. These studies include assessing fluid and vapor leakage during preparation and administration, the impact of CSTDs on environmental contamination and personnel exposure, and the impact of CSTDs on workflow and staffing.

Closed system transfer devices are detailed in a new and comprehensive report researched and written by Greystone Research Associates. Closed System Drug Transfer Devices includes analysis of closed system transfer systems, system design factors, regulatory and industry standards, market data and forecasts, and profiles of market participants.

More information is available at http://www.greystoneassociates.org



Source: Greystone Research Associates

About Greystone

Greystone Research Associates is a medical technology consulting firm focused on the areas of medical market strategy, product commercialization, venture development, and market research. We assist medical and healthcare market participants in achieving their business objectives through the creation of detailed development strategies, product commercialization programs, and comprehensive market and technology research and analysis. Our market research publications are designed, researched and written to provide timely and insightful information and data on focused market segments, with the aim of providing market participants with the essential knowledge to refine and execute their marketing plans and financial targets.

Contact:

Mark Smith
Greystone Research Associates
98 Route 101A
Amherst, NH 03031 USA
Voice: 603-595-4340
Fax: 603-218-7020
www.greystoneassociates.org

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Closed Transfer Systems for Hazardous Drugs Preparing for Change as New Standards Approach here

News-ID: 570867 • Views: 483

More Releases from Greystone Research Associates

Seeking to Capitalize on New Device Technology Drug Companies are Reformulating …
(Amherst, NH) – As the pace of competition increases within the pharmaceutical and biotech industries, the concept of life cycle management is becoming a key component of drug product management. Much of the recent emphasis in this area has centered on efforts to extend patent rights protection. While reformulation has been and is an important approach, efforts to prolong IP benefits have only recently involved IV-to-SC drug re-engineering. This migration
Antibacterial Treatments that don’t Rely on Antibiotics Winding their way thro …
(Amherst, NH) – As bacteria grow resistant to conventional antibiotics, alternatives are being investigated, including antibodies, probiotics, bacteriophages, and antimicrobial peptides. The quest to replace the current generation of antibiotics is complicated by the methods that bacteria have acquired to evade attempts to destroy them – methods often referred to a virulence factors. A microorganism can possess a wide array of virulence factors. They may only express these virulence factors when
3D Printing Positioned to Address Issues that have Prevented Wide Adoption of Mi …
(Amherst, NH) – The promise of commercial microneedle drug delivery has been on the horizon for more than a decade. Like other compelling medical device innovations such as noninvasive glucose monitoring, the potential of the technology has yet to be realized due to the inability to solve the issues of reliable product performance from unit to unit and across a wide user population. To fully address the unmet need these technologies
Analysis of the Oncology Drug Pipeline Reveals Evolving Therapy Correlations and …
(Amherst, NH) – The almost two thousand active oncology clinical trials paint a picture of an evolving therapeutic sector that has established players moving quickly to realize the expanded benefits of recent treatment protocols. A dozen targeted treatments, using novel pathways and signaling, have achieved results that represent a new era in oncology and antineoplastic therapeutics. There approaches have attracted a growing number of drug developers anxious to profit from

All 5 Releases


More Releases for CSTD

Global Closed System Drug Transfer Device (CSTD) Sales Market Report 2018|Global …
A newly compiled business intelligent report, titled “Global Closed System Drug Transfer Device (CSTD) Sales Market Report 2018” has been publicized to the vast archive of Market Research Hub (MRH) online repository. The study revolves around the analysis of (Closed System Drug Transfer Device (CSTD)) market, covering key industry developments and market opportunity map during the mentioned forecast period. This report further conveys quantitative & qualitative analysis on the concerned
Needlefree Closed System Transfer Device (CSTD) Market will reach 1160 million U …
New report published by Global Info Research which offers insights on the global Needlefree Closed System Transfer Device (CSTD) market. Closed System Transfer Device (CSTD) is a drug transfer device that mechanically prohibits the transfer of environmental contaminants into a system and the escape of hazardous drug or vapor concentrations outside the system, which designed to prevent the escape of hazardous drug vapors into the environment during drug reconstitution and administration.
Global Closed System Drug Transfer Device (CSTD) Market Insights, Forecast to 20 …
In the recently published report, QY Research has provided a unique insight into the global Closed System Drug Transfer Device market for the forecasted period of 7-years (2018-2025). The report has covered the significant aspects that are contributing the growth of the global Closed System Drug Transfer Device market. The primary objective of this report is to highlight the various key market dynamics such as drivers, trends, and restraints that
Global Closed System Drug Transfer Device Cstd Market is expected to 2250 millio …
This report studies the Closed System Drug Transfer Device (CSTD) market size (value and volume) by players, regions, product types and end industries, history data 2013-2017 and forecast data 2018-2025; This report also studies the global market competition landscape, market drivers and trends, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter's Five Forces Analysis. Closed System Drug Transfer Device (CSTD) is a drug transfer device that mechanically
Global Closed System Drug Transfer Device (CSTD) Market In-depth Assessment, Dem …
Qyresearchreports include new market research report Global Closed System Drug Transfer Device (CSTD) Market Research Report 2018 to its huge collection of research reports. This report studies Closed System Drug Transfer Device (CSTD) in Global market, focuses on top manufacturers in global market, with volume and value and market share for each manufacturer, covering global revenue of Closed System Drug Transfer Device (CSTD) was valued at 460.27 M USD in 2017, and
Closed System Transfer Device (CSTD) Market Is Expected To Boom Globally By 2022
Worldwide Market Reports added Latest Research Report titled ” Global (North America, Europe and Asia-Pacific, South America, Middle East and Africa) Closed System Transfer Device (CSTD) Market 2017 Forecast to 2022 ” to its Large Report database. Closed System Transfer Device (CSTD) is a drug transfer device that mechanically prohibits the transfer of environmental contaminants into a system and the escape of hazardous drug or vapor concentrations outside the system,